| P50 | author | Christine Menias | Q93134548 |
| P2093 | author name string | Awais Ashfaq | |
| | Nabil Wasif | |
| | Sanjay Bagaria | |
| | C Dan Johnson | |
| | Kristina Flicek | |
| P2860 | cites work | Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique | Q73327596 |
| | Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group | Q73834872 |
| | Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer | Q79372207 |
| | Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q79467684 |
| | Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q81484790 |
| | Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin | Q83389779 |
| | Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools | Q83474834 |
| | Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement | Q35757869 |
| | Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging | Q35841026 |
| | Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence | Q35851521 |
| | Quantitative prognostic indices in peritoneal carcinomatosis | Q36450283 |
| | A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei | Q36629943 |
| | A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma | Q36665886 |
| | Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement | Q37251998 |
| | The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus. | Q37252027 |
| | Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol | Q37308110 |
| | Surgical responsibilities in the management of peritoneal carcinomatosis | Q37761703 |
| | Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment | Q38047539 |
| | Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma | Q38047545 |
| | Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. | Q41146040 |
| | Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei | Q43548703 |
| | Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin | Q43596237 |
| | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. | Q43703526 |
| | 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer | Q43941230 |
| | Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy | Q44911605 |
| | Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. | Q51637241 |
| | Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. | Q51936226 |
| | Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei | Q57121135 |
| | Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy | Q57846338 |
| | Pseudomyxoma peritonei of appendiceal origin. The memorial sloan-kettering cancer center experience | Q67490868 |
| | The management of pseudomyxoma peritonei | Q68546659 |
| | Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery | Q71796147 |
| | Evaluation of computed tomography in patients with peritoneal carcinomatosis | Q72873199 |
| P433 | issue | 2 | |
| P921 | main subject | pseudomyxoma peritonei | Q574694 |
| | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 307-312 | |
| P577 | publication date | 2015-07-11 | |
| P1433 | published in | Journal of Gastrointestinal Surgery | Q15764393 |
| P1476 | title | Correlation of Radiologic with Surgical Peritoneal Cancer Index Scores in Patients with Pseudomyxoma Peritonei and Peritoneal Carcinomatosis: How Well Can We Predict Resectability? | |
| P478 | volume | 20 | |